Sept 5 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :
* TAKEDA ISSUES US RECALL OF NATPARA® (PARATHYROID HORMONE) FOR INJECTION DUE TO THE POTENTIAL FOR RUBBER PARTICULATE
* TAKEDA - RECALL IS EFFECTIVE IMMEDIATELY DUE TO POTENTIAL ISSUE RELATED TO RUBBER PARTICULATES ORIGINATING FROM RUBBER SEPTUM OF NATPARA CARTRIDGE
* TAKEDA PHARMACEUTICAL CO LTD - RECALL IS BEING CONDUCTED AFTER DISCUSSIONS WITH FDA